NFGH

Nan Fung Group Holdings Portfolio holdings

AUM $63.4M
This Quarter Return
+13.46%
1 Year Return
+35.61%
3 Year Return
+215.98%
5 Year Return
10 Year Return
AUM
$156M
AUM Growth
+$156M
Cap. Flow
-$1.68M
Cap. Flow %
-1.07%
Top 10 Hldgs %
79.2%
Holding
49
New
5
Increased
3
Reduced
6
Closed
6

Sector Composition

1 Healthcare 99.77%
2 Technology 0.23%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$48.9M 31.28% 225,688
ILMN icon
2
Illumina
ILMN
$15.8B
$22.3M 14.28% 119,196
HRMY icon
3
Harmony Biosciences
HRMY
$2.12B
$13M 8.29% 368,665
SGEN
4
DELISTED
Seagen Inc. Common Stock
SGEN
$9.06M 5.79% 47,096
OCS icon
5
Oculis Holding
OCS
$844M
$8.03M 5.13% 651,100
EXAI
6
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$5.09M 3.25% 859,892
ISEE
7
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$4.41M 2.82% 111,984
XENE icon
8
Xenon Pharmaceuticals
XENE
$2.98B
$4.4M 2.81% 114,380
KDNY
9
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$4.38M 2.8% 113,950
REPL icon
10
Replimune Group
REPL
$422M
$4.29M 2.74% 184,739 -4,600 -2% -$107K
MRUS icon
11
Merus
MRUS
$4.98B
$3.98M 2.54% 151,000
SLGC
12
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$3.92M 2.5% 1,696,558
ONC
13
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
$2.14M 1.37% 12,022
RANI icon
14
Rani Therapeutics
RANI
$24.4M
$2.03M 1.3% 493,584
INCY icon
15
Incyte
INCY
$16.5B
$1.99M 1.27% 32,022 -2,369 -7% -$147K
GRTX
16
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$1.91M 1.22% 613,223
KALV icon
17
KalVista Pharmaceuticals
KALV
$678M
$1.84M 1.18% 204,720 +126,000 +160% +$1.13M
PACB icon
18
Pacific Biosciences
PACB
$393M
$1.82M 1.16% 136,655
BOLT icon
19
Bolt Biotherapeutics
BOLT
$9.85M
$1.49M 0.95% 1,166,952
GERN icon
20
Geron
GERN
$893M
$1.25M 0.8% +388,000 New +$1.25M
EXEL icon
21
Exelixis
EXEL
$10.1B
$1.23M 0.78% 64,200
BMEA icon
22
Biomea Fusion
BMEA
$116M
$878K 0.56% 40,000 -20,000 -33% -$439K
JBIO
23
Jade Biosciences, Inc. Common Stock
JBIO
$258M
$822K 0.53% 47,936
TRDA icon
24
Entrada Therapeutics
TRDA
$208M
$743K 0.47% 49,082 -24,500 -33% -$371K
EAR
25
DELISTED
Eargo, Inc. Common Stock
EAR
$729K 0.47% 147,904